A proportion of non-enhancing intrinsic presumed low-grade-gliomas(LGG), rapidly progresses. Hypothesis: ADC can predict glioma molecular subtypes of the revised 2016 World_Health_Organization brain tumours classification. Methods..44 non-Gadolinium-enhancing LGG divided in three molecular subgroups. 2D and 3D T2-derived tumour and normal-appearing-white-matter (NAWM) masks co-registered to ADC_maps(b=1000s/mm2). Linear-regression, ROC-analysis and logistic-regression compared ADC_values with tumour type. Results..ADCmean and ADCratio(tumour/NAWM) were lowest (p<0.001) in the most malignant tumour type (IDHwt). An ADCmean(ADCratio) threshold of 1201*10-6mm2/s(1.65) identified IDHwt with sensitivity=83%(80%) and specificity=86%(92%) (AUC=0.9-0.94). Between-observers (2D-versus-3D) intraclass-correlation-coefficient=0.98(0.92). Conclusions..ADC measurements can support the distinction of non-enhancing glioma subtypes. 3D and 2D measurements were both accurate.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords